Timo Rintamäki is an Associate Professor at the Faculty of Management and Business , Tampere University . His research focuses on customer value creation, service ecosystems, and retail innovation, with particular expertise in co-creation, sharing economy platforms, and digital transformation. Research Themes : Customer Value Propositions, Service Ecosystems, E-Commerce, Co-Creation, Retail Experience Design Key Sectors : Retail, Healthcare, Social Media, Public Services Timo’s recent work explores sustainable value creation through collaborative platforms, analyzing customer behavior in online return processes, and optimizing value orchestration in multi-channel environments. His studies span both academic and practical perspectives, including policy implications in healthcare and innovation in consumer cooperatives. His scholarly contributions include frameworks for service experience management, insights into customer data utilization, and models for value co-creation across digital and physical touchpoints. While no specific scientific awards are listed, his interdisciplinary research bridges service science, marketing, and organizational behavior.
Rahul Mangharam is a Professor in the Department of Electrical and Systems Engineering at the University of Pennsylvania's School of Engineering and Applied Science, with a secondary appointment in Computer and Information Science. He directs the Safe Autonomous Systems Lab (mLAB) and is a founding member of the PRECISE Center. Mangharam serves as Penn Director for the Safety21 DoT National University Transportation Center ($20MM), Director of the Autoware Center of Excellence, and leads the F1Tenth Autonomous Racing Community. Education: Ph.D. in Electrical & Computer Engineering, Carnegie Mellon University M.S. in Electrical & Computer Engineering, Carnegie Mellon University B.S. in Electrical & Computer Engineering, Carnegie Mellon University His research bridges formal methods, machine learning, and control systems with applications in medical devices, autonomous systems, and energy-efficient buildings. Key focus areas include safety verification for autonomous vehicles, real-time control systems, and patient-specific cardiac modeling for clinical applications. Recent work explores conformal prediction for safe perception, differentiable control barrier functions, and explainable autonomous systems. Mangharam's publication trends show strong emphasis on autonomous systems safety (control synthesis, uncertainty quantification) and biomedical applications (cardiac modeling, clinical decision support). His 2022-2023 publications demonstrate cross-disciplinary approaches combining control theory, machine learning, and formal methods for robust autonomous systems. Awards and Honors: Presidential Early Career Award (PECASE) 2016 IEEE Benjamin Franklin Key Award 2014 NSF CAREER Award 2013 Intel Early Faculty Career Award 2012 National Academy of Engineers US Frontiers of Engineering (2012, 2018) Stephen J. Angelo Term Chair (2008-2013) He leads multiple major grants including NSF CAREER, DoT Safety21 Center ($20MM), DoE Energy-Efficient Building Hub ($160MM), and DARPA HACMS. Current PhD students include Zirui Zang. Mangharam founded the F1Tenth autonomous racing platform used globally for education and hosts international competitions through the Autoware Center of Excellence.
Dana Pe'er is a Professor and Chair of the Computational and Systems Biology Program at the Sloan Kettering Institute (SKI) of Memorial Sloan Kettering Cancer Center. She is also an Investigator of the Howard Hughes Medical Institute and holds the Alan and Sandra Gerry Endowed Chair. Dr. Pe'er leads an interdisciplinary research group that combines advanced genomics approaches with machine learning to address fundamental questions in biomedical science, with particular focus on cancer biology, developmental biology, and immunology. Dr. Pe'er earned her PhD from Hebrew University in Jerusalem, Israel. Her academic journey includes a postdoctoral fellowship with George Church at Harvard Medical School. Before joining Memorial Sloan Kettering Cancer Center in 2016, she held faculty positions at Columbia University. Dr. Pe'er's research focuses on understanding cellular plasticity, the consequences of intra-tumor heterogeneity, cancer evolution and metastasis, and the mechanisms by which regulatory circuits go awry in disease. Her lab combines single-cell and spatial profiling technologies with machine learning approaches to investigate gene regulation, cellular plasticity, and cell-cell communication in the contexts of cancer, immunity, and development. They are particularly interested in how organisms develop from a single cell to generate diverse cell types, how epigenetic control rewires during development, and how cells communicate to execute multicellular responses. Analysis of Dr. Pe'er's recent publications reveals a strong focus on developing computational methods for single-cell and spatial genomics data analysis. Her work spans cancer types including pancreatic, prostate, colorectal, and breast cancer, with emphasis on tumor heterogeneity, metastasis mechanisms, and cellular plasticity. A significant portion of her research involves creating novel algorithms and tools like CellRank, REUNION, and SEACells that enable researchers to extract meaningful biological insights from complex genomic datasets. 2023 Class of 2023 Inductee - American Academy of Cancer Research (AACR) Academy 2023 Innovator Award - International Society for Computational Biology (ISCB) 2021 Fellow - International Society for Computational Biology (ISCB) Howard Hughes Medical Institute Investigator (2021) 2019 Ernst W. Bertner Memorial Award - University of Texas MD Anderson Cancer Center 2016 Lenfest Distinguished Faculty Award - Columbia University 2014 Director's Pioneer Award - National Institutes of Health 2014 Overton Prize - International Society for Computational Biology (ISCB) Dr. Pe'er is known for her dedicated mentorship approach, describing herself as "a mama bear" who cares deeply about her trainees while expecting independence, innovation, and hard work. She mentors numerous PhD students and postdocs in her lab. Her HHMI Investigator award provides approximately $9 million over seven years, enabling ambitious research directions. She also collaborates extensively with the Single-cell Analytics and Innovation Lab (SAIL) at MSK to generate new data from emerging technologies, working closely with wet-lab collaborators at MSK and beyond to apply computational methods to cutting-edge datasets across multiple disease areas. The Pe'er Lab is an interdisciplinary group of computational biologists with diverse backgrounds ranging from pure mathematics to clinical medicine. They work closely with wet-lab collaborators to apply their computational methods to cutting-edge datasets across cancer, immunology, and developmental biology. The lab is described as open, supportive, collaborative, and fun, with access to world-class facilities at the Sloan Kettering Institute. Dr. Pe'er's work continues to push the boundaries of computational biology and cancer research, with the ultimate goal of developing more effective, personalized therapies for cancer patients.
Mo Mansouri is a Teaching Professor and Director of Graduate Studies at the Department of Systems and Enterprises, Charles V. Schaefer, Jr. School of Engineering and Science, Stevens Institute of Technology. He also serves as a Visiting Professor at the University of North-Eastern Norway, highlighting his international academic engagement. His leadership extends to directing Systems Engineering and Socio-technical Systems Programs, underscoring his central role in shaping academic and research initiatives in systems engineering. Education: PhD in Engineering Management, The George Washington University (2004) MS in Industrial Engineering, University of Tehran (1999) BS in Industrial Engineering, Sharif University of Technology (1997) Dr. Mansouri's research is centered on computational governance frameworks , resilience design , and behavioral modeling in complex socio-technical systems . His work applies systems thinking to urban systems, smart cities, infrastructure, and healthcare, with a strong emphasis on data-driven policy design and multi-stakeholder coordination. He investigates how real-time data, sensing, and analytics can inform governance in complex environments such as transportation, energy, and public health systems. His recent publications (2023–2024) reveal a strong trend toward AI and digital transformation in healthcare , electric and urban mobility systems , and pandemic and societal resilience . These works frequently employ systems thinking, systemigram modeling, and system of systems engineering methodologies, published in IEEE, INCOSE, and IARIA venues. The interdisciplinary nature of his research spans engineering, policy, and human behavior. Scientific Awards and Recognitions: While specific awards are not listed in the provided text, his leadership roles and extensive funding indicate high professional recognition. Advising and Grants: Dr. Mansouri has served as Principal Investigator (PI) or Co-PI on multiple high-value research grants totaling millions of dollars from DoD, Lockheed Martin, NED, and FAA. These projects focus on capability assessment, smart city dashboards, governance modeling, and social development. He mentors students through doctoral and master’s level courses and research, though specific advisee names are not provided. Labs and Research Teams: While specific lab names are not mentioned, his research is conducted within the Department of Systems and Enterprises at Stevens, involving collaborations with students and professionals in areas such as smart cities, healthcare systems, and infrastructure resilience. His work with international institutions and professional societies indicates active participation in global research networks.
Brian W. Pogue, Ph.D., is the Robert A. Pritzker Chair in Biomedical Engineering at Dartmouth College's Thayer School of Engineering, with a joint appointment as an Honorary Fellow in Medical Physics at the University of Wisconsin-Madison. His academic background includes a Ph.D. in Medical/Nuclear Physics from McMaster University and a Research Fellowship at Harvard Medical School's Wellman Center for Photomedicine. He has led significant administrative roles, including Dean of Graduate Studies at Dartmouth (2008–2012) and Chair of Medical Physics at Wisconsin (2022–2025). Research Focus : Dr. Pogue pioneers Optics in Medicine , specializing in cancer imaging, photodynamic therapy, and surgical guidance. His work integrates fluorescence imaging, radiation therapy monitoring, and molecular diagnostics to improve cancer treatment precision. Key innovations include Cherenkov imaging for radiotherapy dosimetry and hypoxia-sensitive probes for tumor resection. Publication Trends : Recent articles (2023–2025) emphasize real-time surgical guidance, hypoxia quantification, and multimodal imaging systems. Dominant themes include fluorescence tomography, radiation dosimetry, and low-cost diagnostic devices, reflecting a translational focus from preclinical validation to clinical applications. Awards & Honors : Fellow, Optica (formerly OSA) Fellow, American Institute for Medical and Biological Engineering (AIMBE) Fellow, American Association of Physicists in Medicine (AAPM) Fellow, SPIE (International Society for Optics and Photonics) Funding & Innovation : Continuously funded by the NIH since 2001 ($52M+ total), Dr. Pogue founded three startups: DoseOptics LLC (radiotherapy dose imaging) and Hypoxia Surgical LLC (tissue hypoxia cameras), bridging academic research to clinical tools.
Mathias Funk is an Associate Professor in the Industrial Design department at Eindhoven University of Technology (TU/e), leading the Things Ecology lab. His research focuses on designing with data and systems behavior, particularly in IoT and medical technology contexts. He co-founded UXsuite GmbH and developed the OOCSI communication framework. With a PhD in Electrical Engineering from TU/e (2011), Funk has held academic roles since 2013, including postdoctoral positions in Electrical Engineering and Industrial Design. He teaches courses like 'Data-enabled design' and supervises projects on AI, data foundry, and OOCSI applications. His work bridges engineering and design, addressing sustainability and human values through systemic design approaches. Education: PhD in Electrical Engineering, TU/e (2011) Computer Science background from RWTH Aachen Postdoc at TU/e's Electrical Engineering and Industrial Design departments Research Interests: Data-driven design methodologies, IoT systems, medical technology innovation, sustainable design practices, and interactive systems for musical expression. Recent work emphasizes telemonitoring efficacy in heart failure care and federated learning applications. Awards: Best Paper Award (2014) Honorable Mention (2021) Grants/Projects: Leading initiatives like MEDICAID (medtech solutions), ACACIA (interpretable AI), and Data-Driven Servitizing in Professional Printing. Active in clinical workflow prototyping and cardiovascular disease detection projects. Lab Activities: Manages the Things Ecology lab, focusing on systemic design challenges in smart ecosystems. Collaborates internationally through spin-offs and visiting lectureships.
Professor Hak-Kim Chan of the Sydney Pharmacy School at the University of Sydney is a world-renowned expert in respiratory drug delivery, particularly pulmonary aerosols and inhalation therapies. With over 480 publications and 17,580+ Google Scholar citations, he has pioneered advancements in powder formulation , in silico modeling , and clinical applications of inhalation technologies. His work includes the development of FDA-approved diagnostics like Aridol™ (inhaled mannitol for asthma) and Bronchitol™ (for cystic fibrosis), and groundbreaking research on inhaled bacteriophage therapy to combat antibiotic-resistant respiratory infections. Education: BPharm (University Medal, 1983), PhD (1988), DSc (2009) from University of Sydney Professional Experience: Postdoc at University of Minnesota (1988–89), Scientist at Genentech Inc. (1992–95) Leadership: Executive Editor of Advanced Drug Delivery Reviews , Fellow of AAPS and RACI His research spans in vitro production methods, computational modeling of inhaler design, and in vivo imaging of aerosol deposition. Current projects focus on nanomedicine , phage therapy , and combating superbugs via inhalation routes. He has secured significant recognition for his work, including NHMRC case studies highlighting public health impacts. Professor Chan has supervised numerous researchers, including PhD student Grace YAU studying pulmonary probiotic delivery . His team's 10 patents (7 as first inventor) reflect practical innovations in dry powder inhalers , antimicrobial formulations , and drug stabilization technologies.
Clinical Associate Professor Keith Ong is affiliated with the University of Sydney’s Northern Clinical School, specifically within the Department of Clinical Ophthalmology & Eye Health. His clinical specialty is Ophthalmology, with a focus on corneal endothelial health, glaucoma surgery outcomes, and cataract surgical techniques. His research addresses critical areas such as postoperative ocular toxicity, intraocular lens calculations, and infection control in eye surgeries. Dr. Ong’s publications (2011–2023) consistently explore topics like corneal endothelial changes post-trabeculectomy, refractive error management post-cataract surgery, and antibiotic prophylaxis strategies. Recent work emphasizes optimizing surgical techniques to reduce complications, such as BAK-induced corneal toxicity and IOL power calculation accuracy in LASIK patients. His work demonstrates a focus on improving surgical safety and precision, with studies evaluating alternative antibiotic delivery methods and laser therapy impacts. No awards or grants are explicitly noted in the provided text, but his contributions to clinical practice and surgical protocols are evident through his publication record.
Dr Anandadeep Mandal is an Associate Professor in Finance and the Scotcoin Distinguished Chair of Digital Finance at the University of Birmingham , within the Birmingham Business School and the Department of Finance . He is the founding director of the MSc Financial Technology programme and the Programme Director for the MBA (Distance Learning), demonstrating significant leadership in academic program development. Education: PhD in Probability Distribution Fitting, Cranfield University (2016) MRes in Management Science, Cranfield University (2012) MSc in Finance and Investments, Durham University (2008) Bachelor’s in Electronics Engineering Research Interests: Dr Mandal’s interdisciplinary research lies at the intersection of mathematical modelling, artificial intelligence, finance, and digital innovation . His work focuses on AI-enabled investment strategies , blockchain for financial transparency , ESG performance measurement , and the development of the Sustainable Efficiency Index (SEI) . He also pioneers AI applications in digital education , including a patent-pending platform for automated grading of multi-modal student submissions using ensemble AI methods. Publication Trends: His recent scholarly output spans high-impact journals and conferences, reflecting a strong focus on digital finance , climate and social media analytics , cryptocurrency regulation , and AI in financial forecasting . His work combines advanced data science techniques with real-world policy and financial applications, particularly in sustainability and public health. Scientific Awards: No specific awards are mentioned in the provided text. Advising and Grants: Dr Mandal has secured over £2 million in research funding from sources including UKRI, UoB QR Funding, and industry partners. While specific students are not listed, his role as programme director and research leader suggests active mentorship. His research has direct policy impact through collaborations with the NHS Trusts , NIHR , and the UK Government . Labs, Teams, and Impact: Dr Mandal leads a research agenda that bridges academia and public policy. His work extends beyond the university through public engagement at science festivals, outreach for young learners, and expert contributions to UK Parliamentary consultations on AI, sustainability, and financial innovation. He is a key figure in advancing digital finance education and research at the University of Birmingham.
Anders Krogh is a Professor at the Department of Computer Science, University of Copenhagen, and also holds a position at the Department of Public Health in the Section for Health Data Science and AI. He serves as the head of the Center for Health Data Science (HeaDS) in the Faculty of Health and Medical Sciences. Previously, he was affiliated with the Department of Biology at the University of Copenhagen until 2020. Dr. Krogh earned his PhD in theoretical physics but transitioned into machine learning and bioinformatics during his doctoral studies. His research spans both theoretical foundations and practical applications in these fields. He is particularly renowned for his pioneering work on hidden Markov models for biological sequences, which has had significant impact in computational biology. In recent years, Krogh's research has focused on deep generative models applied to gene expression data and other biomedical applications. His work bridges computer science with healthcare, developing AI-driven approaches for precision medicine, cancer diagnostics, and analysis of complex biological systems. His current research integrates machine learning with quantum computing applications in biomolecular modeling. Analysis of his recent publications reveals a strong trend toward applying artificial intelligence to healthcare challenges, particularly in rare diseases, cancer diagnostics, and personalized medicine. His work increasingly incorporates federated learning approaches to address privacy concerns while enabling collaborative research across institutions. There's also a growing emphasis on quantum computing applications in biomolecular modeling and drug discovery. As head of the Center for Health Data Science, Krogh leads interdisciplinary research efforts that bring together computer scientists, medical researchers, and clinicians. His team develops novel computational frameworks like MOSAIC for multimodal analysis of rare cancers and multiDGD for multi-omics data integration. These tools are designed to translate AI innovations into clinical practice while addressing the unique challenges of medical data.
FOO Chuan De is a Research Fellow (Adjunct) at the NUS Saw Swee Hock School of Public Health. His research focuses on Primary Healthcare, Healthcare Financing, Pandemic Preparedness, and Health Systems Strengthening. He holds a Master of Public Health (MPH) from the same institution. He serves as Regional Leader (Western Pacific) for the International Working Group on Health Systems Strengthening and collaborates with the WHO Independent Panel on Pandemic Preparedness and Response. Additionally, he is an Associate Editor for the Journal of Migration and Health and a Health Policy Correspondent for the International Health Policy Platform (Antwerp). His work contributes to global health policy through initiatives like the NUS Lancet PRIME Commission. His research spans pandemic response strategies, healthcare system integration, and chronic disease management. While no specific awards are listed, his publications reflect significant contributions to public health policy and practice. He actively engages in editorial and consulting roles to advance health systems resilience and patient-centered care.
Dr. Nivee Pradip Amin serves as Clinical Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at NewYork-Presbyterian Hospital, holding leadership roles as Associate Director for Consultative Cardiology and Director of the Women's Heart Program & Preventive Cardiology. Her clinical expertise spans general cardiology, preventive cardiology, and echocardiography with focus on high-risk cardiovascular prevention. Her educational credentials include: B.A., B.S. in International Studies and Business from University of Pennsylvania (2002) M.D. from Johns Hopkins University School of Medicine (2007) M.H.S. in Clinical Investigation from Johns Hopkins Bloomberg School of Public Health (2013) Research centers on sex-based disparities in cardiovascular outcomes, women's heart health across the lifespan, and preventive strategies for coronary/valvular disease. She investigates intersections between cardiology and obstetrics/oncology, emphasizing personalized risk assessment and early intervention to improve quality of life. Analysis of her publications reveals consistent focus on women's cardiovascular biomarkers (e.g., breast arterial calcium), obstetric complications as long-term risk factors, and disparities in revascularization outcomes. Her work leverages large-scale database analysis to address gaps in preventive care for high-risk populations including cancer patients and those with cirrhosis. Dr. Amin maintains active board certifications in Internal Medicine, Cardiovascular Diseases, Nuclear Cardiology, and Echocardiography through the American Board of Internal Medicine, and holds professional memberships in the American College of Cardiology, American Society for Preventive Cardiology, and American Heart Association. She provides inpatient consultative care on cardiac telemetry units while leading the Women's Heart Program, which integrates preventive cardiology services with gender-specific treatment protocols. Fluent in Spanish, she emphasizes culturally competent care tailored to individual patient needs across diverse populations.
Dr. Mark Gardner is a Research Fellow in Clinical Imaging at the ACRF Image X Institute, part of the University of Sydney's Sydney School of Health Sciences and Faculty of Medicine and Health. His work focuses on advancing radiation therapy and medical imaging technologies, with particular emphasis on improving treatment accuracy and patient comfort. Gardner holds a PhD from Flinders University, completed in collaboration with the Medical Device Research Institute, and has held research roles at the Cystic Fibrosis Airway Research Group (CFARG). His current projects include the Nano-X radiation therapy device and the Remove the Mask initiative , which aims to eliminate immobilization masks in head and neck cancer treatments. Gardner is affiliated with organizations like the IEEE Engineering in Medicine and Biology Society and the American Association of Physicists in Medicine. Research interests span radiation oncology, translational research in medical imaging, and device innovation. His work integrates advanced imaging techniques (e.g., synchrotron X-rays, cone-beam CT) with machine learning and wearable sensors to address challenges in respiratory therapy and tumor targeting. Notable contributions include developing real-time motion tracking for radiation therapy and improving mucociliary transport measurements. Awards: FameLab 2020 State Finalist, 2018 Medtech e-Challenge Winner, 2017 3MT Runner-Up Grants/Projects: Nano-X radiation therapy development, Remove-the-Mask surface-guided system Collaborations: Industry partnerships, multi-institutional research networks Gardner advises Chen Cheng on real-time head/neck motion monitoring during radiation therapy. His lab contributes to open-source tools and preclinical imaging advancements, bridging engineering and clinical oncology.
Donald Rio holds the Richard and Rhoda Goldman Distinguished Chair in the Biological Sciences and is a Professor of Biochemistry, Biophysics, and Structural Biology. He is affiliated with the Division of Biochemistry and Molecular Biology and the Center for Integrative Genetics. His lab focuses on nucleic acid transactions, including transposable element mobilization (P elements) and RNA binding protein mechanisms controlling alternative splicing. Research highlights include studies on THAP9 proteins in humans/zebrafish, cryo-EM structural analysis of transposase-DNA complexes, and splicing regulation in neurodegenerative diseases like ALS and Parkinson’s. His work combines biochemical, genetic, and computational approaches, including the development of the Junction Usage Model (JUM) for splicing analysis. Research interests span transposition mechanisms linked to HIV integration, immune system recombination, and evolutionary genome dynamics. His team investigates how RNA binding proteins like hnRNPA1 influence splicing in disease contexts, with projects involving CRISPR-based models and patient RNA-seq data analysis. Collaborations include studies on splicing accuracy across tissues and age, and the impact of splicing defects in neurodegenerative disorders. Key awards include the Goldman Chair. His lab’s contributions bridge fundamental molecular mechanisms with translational applications in genetic disease modeling and drug discovery. Recent work focuses on isogenic stem cell models (iSCORE-PD) for Parkinson’s research and structural biology insights into transposase function. Grants and projects involve NIH funding for ALS splicing studies and collaborations with institutions like the Buck Institute. His lab actively publishes in top journals such as Genome Research , PNAS , and Nature , with a strong emphasis on cryo-EM and bioinformatic methods.
Jeff Searl is a Professor in the Department of Communicative Sciences and Disorders at Michigan State University (MSU), within the College of Communication Arts and Sciences. Previously, he held faculty roles at the University of Kansas Medical Center’s Hearing and Speech Department and the Otolaryngology – Head & Neck Surgery Department. He earned his Ph.D. from the University of Kansas. His research focuses on understanding how chemoradiation and surgery for head and neck cancers affect speech and voice production. The goal is to develop clinical practices that preserve or rehabilitate communication for patients post-treatment. His methods include physiological, acoustic, and auditory-perceptual measurements. Key emphases include optimizing communication while balancing speech intelligibility, physical/cognitive effort, and associated fatigue. Recent work addresses pandemic impacts on laryngectomy patients, clinician practices during crises, and vocal effort measurement across cultures. His lab investigates articulatory pressures, tracheoesophageal speech dynamics, and dysphagia treatment innovations. Though no specific awards are listed, his contributions to voice rehabilitation and clinical methodologies are significant. Dr. Searl advises on telemedicine applications for Parkinson’s voice therapy, group therapy feasibility, and alaryngeal communication modalities. His lab at MSU collaborates on interdisciplinary projects involving speech-language pathologists, engineers, and oncologists to advance communication restoration technologies.
